Robert Bloder

Commander
DISC Type : D

Chief Business Officer & Board Member at Ascendia Pharmaceutical Solutions

North Brunswick, New Jersey, United States

Overview

Robert is the Chief Business Officer at Ascendia Pharmaceutical Solutions, specializing in global business development and M&A for pharma, generics, and CDMOs. An alumnus of the University of Michigans business school, he is described by colleagues as a high-caliber executive with strong strategic vision and an ability to make things happen.

He is actively engaged in the broader pharmaceutical community, frequently attending major industry events and conferences in the New York and New Jersey area. Robert shows a keen interest in supporting science advocacy and education through organizations like the Liberty Science Center and BioNJ.

Unique fact: Robert holds a patent for a "Method for Selling and Distributing Pharmaceuticals" and is a Certified Master Trainer.

Personality Overview

Candid & Clear

Strong-Willed

Impact-Driven

They respond better to strong and respectful interactions.  They like to be in a position where they can control the conversation and terms. More than the product, they care about the effectiveness of the product.

Topics They Care About

Pharma BD&L
His entire career is focused on Business Development & Licensing, from building global teams at Apotex to his current CBO role driving partnerships and M&A.
CDMO Growth
As CBO of a specialty CDMO, he is focused on strategies to become a “partner of choice” and drive portfolio growth and performance for Ascendia.
Drug Delivery Tech
He has published on transdermal drug delivery and leveraged unique manufacturing technologies in past roles. A recent post also highlights an interest in Lipid Nanoparticles (LNP).

Media Appearances

Chief Business Officer to Sit on CDMO Panel at CPhI North America. Featured in Ascendia Pharmaceutical Solutions (Newsroom)

See Now

Ascendia Pharmaceutical Solutions Launched to Meet Drug Development and Manufacturing Needs. Featured in PR Newswire

See Now

Work History

1-2019
Chief Business Officer & Board Member at Ascendia Pharmaceutical Solutions
2019
Member Board of Directors at Ascendia Pharmaceutical Solutions
3-2018
President at RPM Pharma Consulting, Inc.
2015 - 2018
Vice President Global Business Development at Apotex Inc.
4-2014 - 10-2014
Vice President Business Development at Apotex Inc.

Education

Bachelor of Science - BS from Bethany College
Business from University of Michigan - Stephen M. Ross School of Business

More Information

Social Presence :

Prographics :

Exp : 37 Location : North Brunswick, New Jersey, United States Job Level : Leadership Designation : Chief Business Officer & Board Member at Ascendia Pharmaceutical Solutions
URL has been copied!

Insights For Selling To Robert

During A Call Or A Meeting

DO's

  • Refer to testimonials from well-known industry leaders
  • Speak about competitive differentiation that your product offers
  • Make sure that you circle back fast on any action items, it wins their trust

DONT's

  • Do not back off when challenged, respond with a confident, objective answer instead
  • Do not hesitate from asking counter questions, just avoid challenging their authority
  • Don’t be in a rush to invite them for a social meet and greet

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Robert is

  • Conviction around the impact matters the most to them, followed by a sense of achievement and ROI.
  • Will you ever get a clear answer from Robert

  • If they are not convinced, they will say no without any hesitation.

Insights For Deal Planning

    How fast (or slow) will Robert move?

  • They can take decisions very fast if you manage to convince them.
  • Can Robert take some risk or not?

  • The risks don’t matter much to them.

You And Robert

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.